SYMQY Financials
SymBio Pharmaceuticals Limited - Financial statements & key metrics
Stock Price
$0.56
Market Cap
$51.62M
EPS
$-0.60
Income Statement Highlights
Most Recent Quarter: 2025-12-31
Revenue
$1.37B
Gross Profit
$993.27M
Operating Income
$-4.66B
Net Income
$-5.01B
EPS (Diluted)
$-
Balance Sheet Highlights
Total Assets
$3.87B
Total Liabilities
$2.60B
Shareholders Equity
$1.27B
Cash & Equivalents
$2.89B
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-4.80B
CapEx
$525
Free Cash Flow
$-4.80B
Profitability Metrics
Gross Margin
72.5%
Operating Margin
-3.3%
ROE
-1.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is SYMQY revenue?
SYMQY's most recent quarterly revenue was $1.37B. Annual revenue can be calculated by summing the four most recent quarters.
Is SYMQY profitable?
SYMQY reported a loss of $5.01B in the most recent quarter.
What is SYMQY market cap?
SYMQY has a market capitalization of $51.62M, making it a small-cap stock.
Does SYMQY have debt?
View SYMQY's balance sheet for debt information.
What is SYMQY cash flow?
SYMQY's most recent quarterly free cash flow was $-4.80B.